Author:
Johnson R. D.,Ruthven C. R. J.,Goodwin B. L.,Sandler M.
Publisher
Springer Science and Business Media LLC
Subject
Biological Psychiatry,Psychiatry and Mental health,Clinical Neurology,Neurology
Reference31 articles.
1. Andén, N.-E., Carlsson, A., Kerstell, J., Magnusson, T., Olsson, R., Roos, B.-E., Steen, B., Steg, G., Svanhorg, A., Thieme, G., Werdinius, B.: Oral L-dopa treatment of parkinsonism. Acta med. Scand.187 247 to 255 (1970).
2. Bartholini, G., Burkard, W. P., Pletscher, A., Bates, H. M.: Increase of cerebral catecholamines caused by 3, 4-dihydroxyphenylalanine after inhibition of peripheral decarboxylase. Nature215, 852?853 (1967).
3. Borud, O., Midtvedt, T., Gjessing, L. R.: Urinary metabolites from rats given L-Dopa. Acta Pharmacol. Toxicol.31, 540?549 (1972).
4. Burkard, W. P., Gey, K. F., Pletscber, A.: A new inhibitor of decarboxylase of aromatic amino acids. Experientia18, 411?412 (1962).
5. Calne, D. B., Sandler, M.: L-Dopa and parkinsonism. Nature226, 21?24 (1970).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献